Trogenix ltd
Overview
Trogenix Ltd develops precision cancer treatments through its proprietary gene therapy platform, Odysseus®, which targets diseased cell states and behavior.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Trogenix ltd in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.